Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
Rhea-AI Summary
Progyny (Nasdaq: PGNY), a fertility, family building, and women's health benefits solution provider, has scheduled its Q4 and Full Year 2024 financial results announcement for February 27, 2025, after market close. The company will host a conference call at 4:45 p.m. ET, accessible to U.S. participants at 1.866.825.7331 and international participants at 1.973.413.6106 (passcode: 265484).
An audio replay will be available until March 6, 2025, and can be accessed at 1.800.332.6854 (U.S.) or 1.973.528.0005 (international). A live webcast and recording will be available on the company's investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – PGNY
On the day this news was published, PGNY declined 0.32%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2024, after the close of the market on Thursday, February 27, 2025.
The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Tuesday, March 6, 2025, and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
FAQ
When will Progyny (PGNY) release its Q4 and Full Year 2024 earnings?
How can investors access Progyny's (PGNY) Q4 2024 earnings call?
Until when will Progyny's (PGNY) Q4 2024 earnings call replay be available?
Where can I find the webcast of Progyny's (PGNY) Q4 2024 earnings call?
